Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.
According to the World Health Organization, 360 million people worldwide, including 32 million children, suffer from hearing loss caused by congenital defects or other factors. These factors include infectious disease, use of certain medicines, or exposure to excessive noise. Yet, there are currently no FDA-approved drugs to prevent or treat hearing loss.
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs for their ability to protect cochlear cells from the chemotherapy agent cisplatin. Cisplatin is used to treat a variety of cancers but causes irreversible hearing loss in up to 70% of patients.
Zuo and colleagues identified multiple compounds that protected cochlear cells from cisplatin, several of which are already approved to treat other conditions. Three of the ten most effective compounds were inhibitors of an enzyme called CDK2. One of these CDK2 inhibitors, kenpaullone, was more effective than four other compounds that are currently in clinical trials for treating hearing loss.
Injecting kenpaullone into the middle ear protected both mice and rats from cisplatin-induced hearing loss. Moreover, kenpaullone also protected the hearing of mice to noise as loud as 100 dB. “Given that 100-dB noise is in the range of noise insults commonly experienced by people in our society, kenpaullone could have significant clinical application in treating noise-induced hearing loss,” says Zuo.
In the case of cisplatin-induced hearing loss, kenpaullone appears to protect hair cells by preventing CDK2 from stimulating the production of toxic reactive oxygen species from the cells’ mitochondria.
“The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients,” Zuo says. “Modifications of the treatment regimens, additional optimization of the delivery methods via the use of hydrogels, and structural modifications of the compounds via medicinal chemistry could ensure even better results with CDK2 inhibitors in treating hearing loss in humans.”
The Latest on: Hearing loss
via Google News
The Latest on: Hearing loss
- 'Don't be stupid:' Man who suffered hearing loss, mental problems after COVID has a messageon January 19, 2021 at 6:14 am
After being in the ICU for 22 days, COVID-19 survivor Michael Goldsmith's world has changed. He shares his hope for others and hope for his future.
- A New Hearing Aid Delivers 30% More Sound To the Brain Introduced at HearingLifeon January 19, 2021 at 5:05 am
Designed to support your brain for better hearing with less effort. SOMERSET, N.J. (PRWEB) HearingLife is proud to announce that they are now offering the ...
- Sensorion Announces Preclinical Data Demonstrating SENS-401’s Potential to Preserve Residual Hearing After Cochlear Implantationon January 19, 2021 at 3:30 am
Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the developmen ...
- Could hearing loss impact dementia?on January 18, 2021 at 2:02 pm
A study found that older people who received hearing aids within three years of being diagnosed with hearing loss had lower rates of dementia, depression and even falls than those who did not get ...
- Hearing Aids Market: Rising Incidences Of Hearing Loss With Adoption Of Technologically Advanced Devices Propelling The Market Growth By 2025on January 15, 2021 at 1:05 pm
According to the report published by Grand View Research, Inc., the growing geriatric population and increasing incidences of hearing loss in them along with the adoption of technologically advanced ...
- Webinar on mental health and hearing loss set for Feb. 9on January 15, 2021 at 10:15 am
A webinar on the links between hearing loss and mental health will be held on Feb. 9. The webinar will be held by the Health and Human Services Commission’s Office of Deaf and Hard of Hearing Service ...
- Researchers Develop Smart Apps To Help People with Hearing Losson January 13, 2021 at 9:22 am
Dr. Issa Panahi and his team have created smartphone-based apps, including a recent one that uses artificial intelligence, to remove background noise and improve speech perception.
- Emerging reports of hearing loss during the COVID-19 pandemic and the importance of accessibility to audiological serviceson January 12, 2021 at 8:22 am
Abstract: Covid-19 symptoms range from respiratory distress and fever to completely asymptomatic cases. Several viral infections are known to affect the auditory system and recent case studies propose ...
- Tech for Change: Can new gadgets at CES 2021 solve hearing loss?on January 11, 2021 at 8:00 am
CES show, we expect to see a fleet of true wireless earbuds from a variety of companies that aim to help the hard of hearing in groundbreaking ways.
- Relationships are complicated — so is hearing losson January 8, 2021 at 11:23 pm
“Many people expect hearing loss to be like vision loss where everything we see at a specific distance is clear or unclear,” said Saleem Assaf, clinician and hearing instrument specialist at ...
via Bing News